Health
A backbone free energy study of SARS-CoV-2 variants of concern – News-Medical.net
A recent study by scientist Robert Penner at the Institut des Hautes Études Scientifiques in France utilizes free energy calculations to predict effective antiviral…
Each of the three approved vaccines against coronavirus disease 2019 (COVID-19) – Moderna, BioNTech-Pfizer and Oxford-Astrazeneca – generate forms of the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), allowing the immune system to respond with the appropriate antibodies. Since viruses are able to adapt and mutate at high rates, such vaccine cargoes may eventually become ineffective, and thus identifying highly conserved regions of the protein would be useful in the…
-
Business16 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News13 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business13 hours ago1 ASX dividend stock down 43% I’d buy right now